Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Judo Bio Inc.

Judo Bio Inc.

Stage unknownCambridge, MAjudo.bioBiotechnology

Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.

Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Jul 31, 2024
    Form D equity offering · $25.0M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Judo Bio Inc. filed Form D: $25,000,000 sold (indefinite offering), Biotechnology”
  2. May 17, 2024
    Form D equity offering · $5.0M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Judo Bio Inc. filed Form D: $5,000,000 sold of $5,000,000, Biotechnology”
Investors on record
2 edges
People
3 officers, 5 directors
Timeline
2
  1. Aug 16, 2024
    Judo Bio Inc. filed Form D: $25,000,000 sold (indefinite offering), Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jun 3, 2024
    Judo Bio Inc. filed Form D: $5,000,000 sold of $5,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
35 observations
Every observation on this company